Microemulsion Technology provides Podiatrists with better penetration and better results. With small particle size Formula 7®’s antibacterial and antifungal properties deliver the benefit of multiple products in a single tube or jar. The leader in Tolfnaftate Technology since 1986! Formula 7®is the first tolnaftate microemulsion utilizing soluble tolnaftate, the technology developed by the Tetra Corporation.
After easily passing in the U.S. House of Representatives, the Advancing Telehealth Beyond COVID-19 Act is likely to be considered in the Senate following the August recess.
A majority of Medicare beneficiaries who responded to a recent survey indicated their concern that inflation might drive up the cost of their prescription drugs and their Part B premiums.
Power Diary now includes a complete Practice Operations Manual providing a set of policies and procedures that practices can configure to meet their businesses' needs, set standards for the workplace, and maintain professional operations. Developed by a team with over 50 years of industry experience, this game-changing feature is available exclusively to all Power Diary customers!
